IP Library Granted Patent US 12,403,289
Granted Patent B2
US 12,403,289 · App. 17/454,958 · Granted Sep 2, 2025

Systems and methods for percutaneous intravascular access and guidewire placement

Inventor: Brad M. Kellerman (Escondido, CA)
Assignee: AVENU MEDICAL, INC.
A61M25/09041A61M25/0127A61M25/065A61B17/11A61B2017/1103A61B2017/1107A61B2017/1139A61M25/0068A61M25/0108A61M2025/0197A61M2205/0216A61M2205/0244A61M2205/3317A61M2205/3375A61M2205/581A61M2205/582A61M2205/583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,403,289
App. No.
17/454,958
Granted
Sep 2, 2025
Kind
B2
Abstract

A method of creating intravascular access includes positioning the main body of a device within a primary vessel and manipulating a guidewire having a second alignment member to a location proximate to an inner wall of a secondary vessel. Engaging the alignment member of the distal end of the device and the second alignment member of the guidewire through the respective walls of the primary and secondary vessels, so that the device and guidewire are in close proximity and in alignment, thereby pushing the primary and secondary vessels together. Extending the piercing member distally from the main body, through the wall of the primary vessel, and through an adjacent wall of the secondary vessel, so that the end of the piercing member is disposed within the secondary vessel and thereby creating a communicating aperture on the opposing walls of the primary and secondary vessel.

Claims (30)

1. A method of creating intravascular access, comprising:

manipulating a distal end of a device having a first alignment member to a location proximate to an inner wall of a primary vessel;

manipulating a guidewire having a second alignment member to a location proximate to an inner wall of a secondary vessel;

magnetically coupling the first alignment member of the distal end of the device and the second alignment member of the guidewire through the respective walls of the primary and secondary vessels, so that the device and guidewire are in close proximity and in alignment, and thereby pushing the primary and secondary vessels together; and

extending, after the step of magnetically coupling, a piercing member distally from the device, through the wall of the primary vessel, and through an adjacent wall of the secondary vessel, so that the end of the piercing member is disposed within the secondary vessel and thereby creating a communicating aperture on the opposing walls of the primary and secondary vessel,

contacting, during the step of extending the piercing member, the second alignment member with the piercing member to uncouple the magnetically coupled first and second alignment members and move both the second alignment member and the guidewire away from the distal end of the device.

2. The method as recited in claim 1 , further comprising inserting the device into the primary vessel, wherein the inserting step is performed percutaneously.

3. The method as recited in claim 1 , and further comprising a step of withdrawing the device from the primary vessel.

4. The method as recited in claim 1 , wherein the first alignment member on the device is comprised of one or more of a magnetic attachment, a magnetic implant, a proximity sensor, and an ultrasonic sensor.

5. The method as recited in claim 1 , wherein the second alignment member comprises one or more of a magnetic attachment, a magnetic implant, a proximity sensor, and an ultrasonic sensor.

6. The method as recited in claim 1 , wherein the guidewire has a guidewire body, and the second alignment member comprises a magnetic material and projects laterally outward from a lateral-most dimension of the guidewire body.

7. The method as recited in claim 6 , wherein the magnetic material extends laterally from the guidewire body in a first direction and in a second direction opposite the first direction.

8. The method as recited in claim 1 , wherein the guidewire has a guidewire body, the second alignment member having a blunt distal surface extending laterally outward from the guidewire body, the blunt distal surface being configured to move the secondary vessel toward the primary vessel.

9. The method as recited in claim 1 , wherein the guidewire has a guidewire body, an entirety of the second alignment member being disposed distally of the guidewire body.

10. The method as recited in claim 1 , wherein the second alignment member comprises a continuous block of magnetic material.

11. The method as recited in claim 1 , wherein the second alignment member defines a distal surface extending continuously across a distal-most end of the second alignment member.

12. The method as recited in claim 1 , wherein the primary vessel comprises a vein, and the secondary vessel comprises an artery.

13. The method as recited in claim 12 , further comprising creating an arterio-venous fistula (AVF) by connecting the artery to the vein.

14. The method as recited in claim 1 , wherein each of first and second alignment members comprises magnetic material.

15. The method as recited in claim 14 , wherein the magnetic material is permanent magnetic material.

16. The method as recited in claim 14 , wherein at least one of the first and second alignment members further comprises at least one of a proximity detector or an ultrasonic sensor.

17. The method as recited in claim 1 , further comprising:

advancing, after the step of contacting the second alignment member with the piercing member to uncouple the magnetically coupled first and second alignment members, a second guidewire through a lumen of the piercing member so that the guidewire enters the secondary vessel.

18. The method as recited in claim 17 , further comprising:

withdrawing, after the step of advancing the second guidewire through the lumen of the piercing member, the device from the primary vessel.

19. The method as recited in claim 18 , wherein after said withdrawing the device from the primary vessel, the second guidewire extends from the primary vessel, through the communicating aperture, and into the secondary vessel.

20. The method recited in claim 19 , wherein the primary vessel comprises a vein, and the secondary vessel comprises an artery,

wherein the method further comprises:

advancing, after said withdrawing the device from the primary vessel and with the second guidewire extending from the primary vessel, through the communicating aperture, and into the secondary vessel, instrumentation over the guidewire to the communicating aperture; and

creating an arterio-venous fistula (AVF) by connecting the artery to the vein using the instrumentation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2021
From: KELLERMAN, BRAD M.
To: AVENU MEDICAL, INC.
Reel/Frame 058116/0677 →
Continuity (3)
Division 15808711 · Nov 9, 2017
Provisional Application 62421125 · Nov 11, 2016
Related Publication 20220072280A1 · Mar 10, 2022
References Cited (94)
US 5290278A · Anderson · 1994 [cited by applicant]
US 5380292A · Wilson · 1995 [cited by applicant]
US 5425731A · Daniel et al. · 1995 [cited by applicant]
US 5830222A · Makower · 1998 [cited by applicant]
US 5830224A · Cohn et al. · 1998 [cited by applicant]
US 5910133A · Gould · 1999 [cited by applicant]
US 6068637A · Popov et al. · 2000 [cited by applicant]
US 6068638A · Makower · 2000 [cited by applicant]
US 6071292A · Makower et al. · 2000 [cited by applicant]
US 6083223A · Baker · 2000 [cited by applicant]
US 6099542A · Cohn et al. · 2000 [cited by applicant]
US 6190353B1 · Makower · 2001 [cited by examiner]
US 6235027B1 · Herzon · 2001 [cited by applicant]
US 6248117B1 · Blatter · 2001 [cited by applicant]
US 6283983B1 · Makower et al. · 2001 [cited by applicant]
US 6302875B1 · Makower et al. · 2001 [cited by applicant]
US 6330884B1 · Kim · 2001 [cited by applicant]
US 6375615B1 · Flaherty et al. · 2002 [cited by applicant]
US 6379319B1 · Garibotto et al. · 2002 [cited by applicant]
US 6398797B2 · Bombard et al. · 2002 [cited by applicant]
US 6464665B1 · Heuser · 2002 [cited by applicant]
US 6533778B2 · Herzon · 2003 [cited by applicant]
US 6561998B1 · Roth et al. · 2003 [cited by applicant]
US 6579311B1 · Makower · 2003 [cited by applicant]
US 6613081B2 · Kim et al. · 2003 [cited by applicant]
US 6616675B1 · Evard et al. · 2003 [cited by applicant]
US 6669709B1 · Cohn et al. · 2003 [cited by applicant]
US 6699245B2 · Dinger et al. · 2004 [cited by applicant]
US 6709444B1 · Makower · 2004 [cited by applicant]
US 6726677B1 · Flaherty et al. · 2004 [cited by applicant]
US 6863684B2 · Kim et al. · 2005 [cited by applicant]
US 6908463B2 · Treat et al. · 2005 [cited by applicant]
US 6929009B2 · Makower et al. · 2005 [cited by applicant]
US 7004173B2 · Sparks et al. · 2006 [cited by applicant]
US 7056325B1 · Makower et al. · 2006 [cited by applicant]
US 7159592B1 · Makower et al. · 2007 [cited by applicant]
US 7191015B2 · Lamson et al. · 2007 [cited by applicant]
US 7316655B2 · Garibotto et al. · 2008 [cited by applicant]
US 7351247B2 · Kupiecki et al. · 2008 [cited by applicant]
US 7387636B2 · Cohn et al. · 2008 [cited by applicant]
US 7588566B2 · Treat et al. · 2009 [cited by applicant]
US 7729738B2 · Flaherty et al. · 2010 [cited by applicant]
US 7846168B2 · Liddicoat et al. · 2010 [cited by applicant]
US 7846172B2 · Makower · 2010 [cited by applicant]
US 7918865B2 · Liddicoat et al. · 2011 [cited by applicant]
US 8469983B2 · Fung et al. · 2013 [cited by applicant]
US 8771297B2 · Miller et al. · 2014 [cited by applicant]
US 8795310B2 · Fung et al. · 2014 [cited by applicant]
US 8951276B2 · Kellerman et al. · 2015 [cited by applicant]
US 8974473B2 · Kaplan et al. · 2015 [cited by applicant]
US 9198664B2 · Fung et al. · 2015 [cited by applicant]
US 9408608B2 · Clark, III et al. · 2016 [cited by applicant]
US 9522016B2 · Kellerman et al. · 2016 [cited by applicant]
US 9801653B2 · Kellerman et al. · 2017 [cited by applicant]
US 20020032462A1 · Houser et al. · 2002 [cited by applicant]
US 20020120250A1 · Altman · 2002 [cited by applicant]
US 20020169377A1 · Khairkhahan et al. · 2002 [cited by applicant]
US 20030100920A1 · Akin et al. · 2003 [cited by applicant]
US 20030158519A1 · Epstein et al. · 2003 [cited by applicant]
US 20050101984A1 · Chanduszko et al. · 2005 [cited by applicant]
US 20060106278A1 · Machold et al. · 2006 [cited by applicant]
US 20060111704A1 · Brenneman et al. · 2006 [cited by applicant]
US 20060142788A1 · Wilson et al. · 2006 [cited by applicant]
US 20060161193A1 · Beane et al. · 2006 [cited by applicant]
US 20070014283A1 · Strathmeyer et al. · 2007 [cited by applicant]
US 20070203515A1 · Heuser · 2007 [cited by examiner]
US 20080065019A1 · Heuser et al. · 2008 [cited by applicant]
US 20080161904A1 · Heuser et al. · 2008 [cited by applicant]
US 20080171944A1 · Brenneman · 2008 [cited by applicant]
US 20090198153A1 · Shriver · 2009 [cited by applicant]
US 20100222664A1 · Lemon et al. · 2010 [cited by applicant]
US 20110184504A1 · Ward et al. · 2011 [cited by applicant]
US 20110295104A1 · Teitelbaum et al. · 2011 [cited by applicant]
US 20120265229A1 · Rettenberg et al. · 2012 [cited by applicant]
US 20150057687A1 · Gittard et al. · 2015 [cited by applicant]
US 20150182740A1 · Mickelsen · 2015 [cited by applicant]
US 20150297259A1 · Matsubara et al. · 2015 [cited by applicant]
US 20170202616A1 · Pate · 2017 [cited by examiner]
CN 1204242 · 1999 [cited by applicant]
JP 2015504328 · 2015 [cited by applicant]
WO WO199423785 · 1994 [cited by applicant]
WO WO199713463 · 1997 [cited by applicant]
WO WO199713471 · 1997 [cited by applicant]
WO WO2006027599 · 2006 [cited by applicant]
WO WO2007014283 · 2007 [cited by applicant]
WO WO201074153 · 2010 [cited by applicant]
WO WO2013067446 · 2013 [cited by applicant]
WO WO2015195668 · 2015 [cited by applicant]
European Communication Pursuant to Article 94(3) EPC, Application No. 17 870 559.6, May 12, 2022, 5 pages, Berlin, Germany. [cited by applicant]
Japanese Office Action dated May 26, 2020 in corresponding Japanese Application No. 2019-524036 European Supplementary Search Report dated Aug. 28, 2020 in corresponding European Application No. 17870559.6. [cited by applicant]
European Supplementary Search Report dated Aug. 28, 2020 in corresponding European Application No. 17870559.6. [cited by applicant]
European Examination Report Application No. 17870559.6, dated Apr. 6, 2021, 4 pages, Germany. [cited by applicant]
International Search Report and Written Opinion dated Mar. 8, 2018 in connection with corresponding PCT Application No. PCT/US2017/060940. [cited by applicant]
Canadian Examiner's Requisition for Application No. 3,043,175, Apr. 17, 2024, 5 pages. [cited by applicant]